Cargando…

Method development for simultaneous estimation of Amlodipine Besylate and Perindopril Tertbutyl amine in fixed-dose

The fixed-dose combination of Amlodipine Besylate (ADB) with Perindopril Tertbutylamine (PTBA) drug is used to treat patients with mild-to-moderate hypertension. In recent times researchers are interested to find the efficient analytical method development and validation for the simultaneous determi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Muhammad Farooq Saleem, Tahir, Lutafullah, Zhou, Xu, Bary, Ghulam, Sajid, Muhammad, Shahzad, Ahmad Khawar, Khan, Ilyas, Mohamed, Abdullah, Ahmad, Riaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009730/ https://www.ncbi.nlm.nih.gov/pubmed/36923897 http://dx.doi.org/10.1016/j.heliyon.2023.e14209

Ejemplares similares

Method development and validation of HPLC tandem/mass spectrometry for quantification of perindopril arginine and amlodipine besylate combination in bulk and pharmaceutical formulations
por: Duraisamy, Kalaiyarasi, et al.
Publicado: (2017)

Perindopril/amlodipine-induced thrombotic microangiopathy
por: Periša, Vlatka, et al.
Publicado: (2020)

Formulation and Evaluation of S-(-)-Amlodipine Besylate and Nebivolol Hydrochloride Tablets
por: Shaikh, S.A, et al.
Publicado: (2010)

Chronic unilateral chemosis following the use of amlodipine besylate
por: Kim, Kyeong Hwan, et al.
Publicado: (2014)

Efficacy of amlodipine besylate and Valsartan for the treatment of mild to moderate hypertension
por: Wang, Xiao-ou, et al.
Publicado: (2019)

Perindopril/Indapamide/Amlodipine in Hypertension: A Profile of Its Use
por: Syed, Yahiya Y.
Publicado: (2022)

Kinetic spectrophotometric method for determination of amlodipine besylate in its pharmaceutical tablets
por: Mahmoud, Ashraf M., et al.
Publicado: (2012)

Correction to: Perindopril/Indapamide/Amlodipine in Hypertension: A Profile of Its Use
por: Syed, Yahiya Y.
Publicado: (2022)

Estimation of Amlodipine Besylate, Valsartan and Hydrochlorothiazide in Bulk Mixture and Tablet by UV Spectrophotometry
por: Galande, Varsha R., et al.
Publicado: (2012)

Development and Evaluation of Mouth Dissolving Films of Amlodipine Besylate for Enhanced Therapeutic Efficacy
por: Maheswari, K. M., et al.
Publicado: (2014)

Stability Indicating RP-HPLC Estimation of Atorvastatin Calcium and Amlodipine Besylate in Pharmaceutical Formulations
por: Shah, D. A., et al.
Publicado: (2008)

The Effect of Crospovidone on the Dissolution Profile of Amlodipine Besylate from Fast Orally Dissolving Film
por: Sumaiyah, Sumaiyah, et al.
Publicado: (2019)

Effects of Irbesartan and Amlodipine Besylate Tablets on the Intestinal Microflora of Rats With Hypertensive Renal Damage
por: Yu, Jing, et al.
Publicado: (2022)

Molecular dynamics and the translational–rotational coupling of an ionically conducting glass-former: amlodipine besylate
por: K. P, Safna Hussan, et al.
Publicado: (2018)

Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects
por: Lee, Soo-Yun, et al.
Publicado: (2015)

Effectiveness of a Fixed-Dose, Single-Pill Combination of Perindopril and Amlodipine in Patients with Hypertension: A Non-Interventional Study
por: Fleig, Susanne V., et al.
Publicado: (2018)

Development and Validation of HPTLC Method for Simultaneous Determination of Amlodipine Besylate and Metoprolol Succinate in Bulk and Tablets
por: Jain, P. S., et al.
Publicado: (2012)

Preparation and In Vitro Characterization of Mucoadhesive Hydroxypropyl Guar Microspheres Containing Amlodipine Besylate for Nasal Administration
por: Swamy, N. G. N., et al.
Publicado: (2011)

The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension
por: Ruilope, Luis, et al.
Publicado: (2013)

Erratum to: The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension
por: Ruilope, Luis, et al.
Publicado: (2014)

Erratum to: The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension
por: Ruilope, Luis, et al.
Publicado: (2015)

Simultaneous Quantitative Analysis of Olmesartan Medoxomil and Amlodipine Besylate in Plasma by High-performance Liquid Chromatography Technique
por: Shah, SK, et al.
Publicado: (2012)

Development and Validation of a Simultaneous HPLC Method for Estimation of Bisoprolol Fumarate and Amlodipine Besylate from Tablets
por: Vora, D. N., et al.
Publicado: (2008)

Simultaneous Determination of Amlodipine Besylate and Atorvastatin Calcium in Binary Mixture by Spectrofluorimetry and HPLC Coupled with Fluorescence Detection
por: Moussa, Bahia A., et al.
Publicado: (2013)

Plasma Renin Activity and Aldosterone Concentrations in Hypertensive Cats with and without Azotemia and in Response to Treatment with Amlodipine Besylate
por: Jepson, R.E., et al.
Publicado: (2013)

Formulations of Amlodipine: A Review
por: Sheraz, Muhammad Ali, et al.
Publicado: (2016)

Single-Pill Combination of Perindopril/Indapamide/Amlodipine in Patients with Uncontrolled Hypertension: A Randomized Controlled Trial
por: Nedogoda, Sergey V., et al.
Publicado: (2017)

Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis
por: Sievers, Philipp, et al.
Publicado: (2015)

Central Composite Design for Validation of HPTLC Method for Simultaneous Estimation of Olmesartan Medoxomil, Amlodipine Besylate and Hydrochlorothiazide in Tablets
por: Solanki, Trupti B., et al.
Publicado: (2014)

A new stability-indicating HPLC-UV method for determination of amlodipine besylate and its impurities in drug substance
por: Jeelani, Salika, et al.
Publicado: (2023)

Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects
por: Lee, Hae Won, et al.
Publicado: (2020)

Fixed Dose Single Tablet Formulation with Differential Release of Amlodipine Besylate and Simvastatin and Its Pharmacokinetic Profile: QbD and Risk Assessment Approach
por: Kanwal, Ummarah, et al.
Publicado: (2021)

Designing small organic non-fullerene acceptor molecules with diflorobenzene or quinoline core and dithiophene donor moiety through density functional theory
por: Bary, Ghulam, et al.
Publicado: (2021)

Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy
por: Borghi, Claudio, et al.
Publicado: (2023)

Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study
por: Choi, YoonJung, et al.
Publicado: (2016)

Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension
por: Marques da Silva, Pedro, et al.
Publicado: (2015)

Development and Evaluation of Feline Tailored Amlodipine Besylate Mini-Tablets Using l-lysine as a Candidate Flavouring Agent
por: Ekweremadu, Chinedu S., et al.
Publicado: (2020)

Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension
por: Zhang, Lei-Ke, et al.
Publicado: (2020)

N-(2,4,6-Trimethylphenyl)-1,3-thiazol-2-amine
por: Babar, Ayesha, et al.
Publicado: (2012)

Influence of fixed-dose combination perindopril/amlodipine on target organ damage in patients with arterial hypertension with and without ischemic heart disease (results of EPHES trial)
por: Radchenko, Ganna D, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_24e9truaaadgkmvl4c6s6bkke6